NO20042839L - Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister - Google Patents

Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister

Info

Publication number
NO20042839L
NO20042839L NO20042839A NO20042839A NO20042839L NO 20042839 L NO20042839 L NO 20042839L NO 20042839 A NO20042839 A NO 20042839A NO 20042839 A NO20042839 A NO 20042839A NO 20042839 L NO20042839 L NO 20042839L
Authority
NO
Norway
Prior art keywords
adenosine
beta
receptor agonists
adrenergic receptor
pharmaceutical combinations
Prior art date
Application number
NO20042839A
Other languages
English (en)
Inventor
Michael Yeaden
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20042839L publication Critical patent/NO20042839L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO20042839A 2001-12-06 2004-07-05 Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister NO20042839L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129270.5A GB0129270D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
PCT/IB2002/005057 WO2003047598A1 (en) 2001-12-06 2002-11-28 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists

Publications (1)

Publication Number Publication Date
NO20042839L true NO20042839L (no) 2004-07-05

Family

ID=9927164

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042839A NO20042839L (no) 2001-12-06 2004-07-05 Farmasoytiske kombinasjoner av adenosin A-2A og beta-2-adrenerge reseptoragonister

Country Status (38)

Country Link
EP (1) EP1455799B1 (no)
JP (1) JP2005513041A (no)
KR (1) KR100685557B1 (no)
CN (1) CN1856314A (no)
AP (2) AP2004003082A0 (no)
AR (1) AR037634A1 (no)
AT (1) ATE293982T1 (no)
AU (1) AU2002351066B2 (no)
BR (1) BR0214998A (no)
CA (1) CA2469085A1 (no)
CO (1) CO5580752A2 (no)
DE (1) DE60203934T2 (no)
DK (1) DK1455799T3 (no)
EA (1) EA200400639A1 (no)
EC (1) ECSP045132A (no)
ES (1) ES2239728T3 (no)
GB (1) GB0129270D0 (no)
GT (1) GT200200258A (no)
HN (1) HN2002000348A (no)
HR (1) HRP20040517A2 (no)
HU (1) HUP0402540A3 (no)
IS (1) IS7280A (no)
MA (1) MA27150A1 (no)
MX (1) MXPA04005506A (no)
NO (1) NO20042839L (no)
NZ (1) NZ533054A (no)
OA (1) OA12738A (no)
PA (1) PA8560701A1 (no)
PE (1) PE20030834A1 (no)
PL (1) PL370739A1 (no)
PT (1) PT1455799E (no)
PY (1) PY0228254A (no)
SV (1) SV2004001426A (no)
TN (1) TNSN04101A1 (no)
TW (1) TWI256388B (no)
UY (1) UY27566A1 (no)
WO (1) WO2003047598A1 (no)
ZA (1) ZA200403966B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100785969B1 (ko) * 2004-05-12 2007-12-14 동아제약주식회사 Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
CN105473133A (zh) 2013-04-30 2016-04-06 欧缇托匹克公司 干粉制剂及使用方法
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
EP3684338A4 (en) 2017-09-22 2021-06-23 Otitopic Inc. DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE
WO2022050230A1 (ja) * 2020-09-03 2022-03-10 学校法人埼玉医科大学 アデノシン受容体の活性化を抑制する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003960D0 (en) * 2000-02-18 2000-04-12 Pfizer Ltd Purine derivatives
TWI227240B (en) * 2000-06-06 2005-02-01 Pfizer 2-aminocarbonyl-9H-purine derivatives

Also Published As

Publication number Publication date
AU2002351066A1 (en) 2003-06-17
HN2002000348A (es) 2005-02-04
ES2239728T3 (es) 2005-10-01
EA200400639A1 (ru) 2004-12-30
DK1455799T3 (da) 2005-06-27
SV2004001426A (es) 2004-05-07
UY27566A1 (es) 2003-07-31
MA27150A1 (fr) 2005-01-03
AU2002351066B2 (en) 2007-10-18
PA8560701A1 (es) 2004-05-07
HUP0402540A3 (en) 2008-04-28
EP1455799B1 (en) 2005-04-27
KR100685557B1 (ko) 2007-02-22
GT200200258A (es) 2003-08-22
JP2005513041A (ja) 2005-05-12
AR037634A1 (es) 2004-11-17
ZA200403966B (en) 2005-06-22
WO2003047598A1 (en) 2003-06-12
TNSN04101A1 (fr) 2006-06-01
EP1455799A1 (en) 2004-09-15
PT1455799E (pt) 2005-08-31
HUP0402540A2 (hu) 2005-07-28
DE60203934D1 (de) 2005-06-02
PY0228254A (es) 2004-06-01
AP2004003082A0 (en) 2004-09-30
AP2004003053A0 (en) 2004-06-30
GB0129270D0 (en) 2002-01-23
ECSP045132A (es) 2004-07-23
ATE293982T1 (de) 2005-05-15
IS7280A (is) 2004-05-21
MXPA04005506A (es) 2004-12-10
PL370739A1 (pl) 2005-05-30
DE60203934T2 (de) 2006-02-23
TW200300759A (en) 2003-06-16
CN1856314A (zh) 2006-11-01
BR0214998A (pt) 2004-12-28
KR20050044697A (ko) 2005-05-12
TWI256388B (en) 2006-06-11
NZ533054A (en) 2007-02-23
CA2469085A1 (en) 2003-06-12
CO5580752A2 (es) 2005-11-30
HRP20040517A2 (en) 2004-10-31
PE20030834A1 (es) 2003-10-08
OA12738A (en) 2006-06-29

Similar Documents

Publication Publication Date Title
NO20035202D0 (no) En adenosin A2A reseptoragonist og et antikolinergmiddel i kombinasjon forbehandling av obstruktive luftveissykdommer
PT1585548T (pt) Composições e métodos de administração de agentes farmacológicos
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
ATE293627T1 (de) Adenosin a2a rezeptor antagonisten
NO20051493D0 (no) Imidazolpyridiner og fremgangsmater for fremstilling og anvendelse av de samme
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1379224T3 (da) Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20012013D0 (no) 5HT1 reseptor agonister og metoclopramid for behandling av migrene
NO20042272L (no) Farmasoytiske blandinger og fremgangsmater for administrering av EP2-reseptor selektive agonister
PT1208100E (pt) Antagonistas selectivos de receptores de adenosina a2b
NO20035300D0 (no) Aminokinolin- og aminopyridinderivater og deres anvendelse som adenosin A<N>3-ligander
NO20033506L (no) Parasitticidale preparater og metoder for anvendelse
NO995622L (no) Karbocyklisk nukleosidhemisulfat og anvendelse derav for behandling av virale infeksjoner
IS7280A (is) Lyfjafræðilegar samsetningar af adenósín A-2A og Beta-2-adrenvirkum viðtaka gerandefnum
ATE250621T1 (de) Oral aktive a1 adenosin rezeptor agonisten
ITMI20022518A1 (it) Dispositivo e procedimento per minimizzare ritardo di
NO20034172L (no) Bisykliske guanidinderivater og terapeutiske anvendelser derav
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
DE60220713D1 (de) Ribofuranosyluronamid Derivate als Kristall; ein menschlicher Adenosin A2A Rezeptor Agonsit
IL146142A0 (en) 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes
EP1390068A4 (en) PROCESSES AND FORMULATIONS OF A1-ADENOSINE AND P2X-PURINOREZEPTOR ANTAGONISTS
NO20033697L (no) Substituerte propan-1,3-diamin-derivater og den farmasöytiske anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application